Henry F. Blissenbach

Henry F. Blissenbach

82 year
Distribution Services
Health Technology
Health Services

Profile

Henry F.
Blissenbach
, serves as a Director, President and Chief Executive Officer for BioScrip Inc. Dr. Blissenbach was named to this position upon the consummation of the merger between MIM Corporation and Chronimed, Inc. effective March 2005.
Dr. Blissenbach previously served as Chairman and Chief Executive Officer of Chronimed, Inc. He was appointed Chairman of the Board of Directors and Chief Executive Officer of Chronimed on July 1, 2000.
Dr. Blissenbach was named President and Chief Operating Officer of Chronimed in May 1997.
He became a director of Chronimed in September 1995.
From 1992 to 1997, he served as President of Diversified Pharmaceutical Services, Inc., a UnitedHealthcare subsidiary until 1994 and afterwards a subsidiary of SmithKline Beecham Corp.
Diversified Pharmaceutical Services, Inc. was a pharmacy benefit management firm.
Dr. Blissenbach also serves as a director of Ligand Pharmaceuticals Inc., a publicly held biopharmaceutical development company, and Opportunity Partners, Inc., a nonprofit company.

Former positions of Henry F. Blissenbach

CompaniesPositionEnd
Chairman 2004-08-08
President -
LIGAND PHARMACEUTICALS INCORPORATED Director/Board Member -
See the detail of Henry F. Blissenbach's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Henry F. Blissenbach's experience

Linked companies

Listed companies1
LIGAND PHARMACEUTICALS INCORPORATED

Health Technology

Private companies2

Distribution Services

Health Services

  1. Stock Market
  2. Insiders
  3. Henry F. Blissenbach